CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS

MLA

“Chimeric Therapeutics Announces Fda Clearance of Ind Application for Chm 2101, a Novel Cdh17 Car T Cell Therapy for Advanced Gastrointestinal Cancers.” PR Newswire, 31 Oct. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.770915743&authtype=sso&custid=ns315887.

APA

Chimeric Therapeutics Announces Fda Clearance of Ind Application for Chm 2101, a Novel Cdh17 Car T Cell Therapy for Advanced Gastrointestinal Cancers. (2023, October 31). PR Newswire.

Chicago

PR Newswire. 2023. “Chimeric Therapeutics Announces Fda Clearance of Ind Application for Chm 2101, a Novel Cdh17 Car T Cell Therapy for Advanced Gastrointestinal Cancers,” October 31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.770915743&authtype=sso&custid=ns315887.